Xufu Wei

1.2k total citations
33 papers, 890 citations indexed

About

Xufu Wei is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xufu Wei has authored 33 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Xufu Wei's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (7 papers). Xufu Wei is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (10 papers) and Circular RNAs in diseases (7 papers). Xufu Wei collaborates with scholars based in China, United States and Sweden. Xufu Wei's co-authors include Zhongjun Wu, Rui Liu, Chengyong Tang, Cui Tan, Tingxiu Xiang, Guosheng Ren, Daofeng Zheng, Junliang Pu, Tong Mou and Zhen Guo and has published in prestigious journals such as Hepatology, Life Sciences and Cell Reports.

In The Last Decade

Xufu Wei

33 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xufu Wei China 16 544 403 195 166 142 33 890
Cuijuan Zhang China 18 790 1.5× 527 1.3× 118 0.6× 156 0.9× 218 1.5× 39 1.1k
Zhanjun Guo China 21 903 1.7× 433 1.1× 175 0.9× 69 0.4× 180 1.3× 94 1.3k
Pinzhu Huang China 18 513 0.9× 289 0.7× 198 1.0× 79 0.5× 270 1.9× 50 978
Chung-Ta Lee Taiwan 15 420 0.8× 307 0.8× 124 0.6× 72 0.4× 197 1.4× 37 866
Yu Lou China 15 525 1.0× 403 1.0× 143 0.7× 285 1.7× 416 2.9× 28 1.1k
So Mee Kwon South Korea 18 510 0.9× 337 0.8× 113 0.6× 67 0.4× 199 1.4× 29 892
Mariafausta Fischietti United States 15 479 0.9× 276 0.7× 146 0.7× 374 2.3× 317 2.2× 28 1.1k
Katsuhiko Fujikawa Japan 13 631 1.2× 189 0.5× 204 1.0× 164 1.0× 250 1.8× 20 868
Ming-hua Zhu China 21 833 1.5× 461 1.1× 169 0.9× 100 0.6× 289 2.0× 50 1.2k

Countries citing papers authored by Xufu Wei

Since Specialization
Citations

This map shows the geographic impact of Xufu Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xufu Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xufu Wei more than expected).

Fields of papers citing papers by Xufu Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xufu Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xufu Wei. The network helps show where Xufu Wei may publish in the future.

Co-authorship network of co-authors of Xufu Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xufu Wei. A scholar is included among the top collaborators of Xufu Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xufu Wei. Xufu Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qiang, Henrik Nilsson, Keyang Xu, et al.. (2024). Exploring tumor heterogeneity in colorectal liver metastases by imaging: Unsupervised machine learning of preoperative CT radiomics features for prognostic stratification. European Journal of Radiology. 175. 111459–111459. 8 indexed citations
2.
Dong, Ling, Xufu Wei, Le Yu, Yixin Li, & Lixue Chen. (2023). Inhibition of SIRT7 promotes STAT1 activation and STAT1-dependent signaling in hepatocellular carcinoma. Cellular Signalling. 114. 111005–111005. 1 indexed citations
3.
Tang, Wei, Yufei Zhao, Xufu Wei, et al.. (2022). Comparison of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancreatic cancer: A systematic review and meta-analysis. International Journal of Surgery. 103. 106676–106676. 8 indexed citations
4.
Zhou, Jian, Wei-Feng Huang, Yuke Zhang, et al.. (2022). LncRNA RPPH1 acts as a molecular sponge for miR-122 to regulate Wnt1/β-catenin signaling in hepatocellular carcinoma. International Journal of Medical Sciences. 20(1). 23–34. 5 indexed citations
6.
Liao, Rui, et al.. (2021). Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma. Frontiers in Oncology. 11. 697747–697747. 17 indexed citations
8.
Huang, Wei-Feng, et al.. (2021). miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC). Journal of Gastrointestinal Oncology. 12(4). 1811–1822. 12 indexed citations
10.
Pu, Junliang, Zuotian Huang, Yunhai Luo, et al.. (2021). Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway. Hepatobiliary & pancreatic diseases international. 20(4). 352–360. 34 indexed citations
12.
Zheng, Daofeng, et al.. (2018). IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling. Hepatobiliary & pancreatic diseases international. 17(5). 408–415. 9 indexed citations
13.
Tang, Chengyong, et al.. (2018). IL-34 Inhibits Acute Rejection of Rat Liver Transplantation by Inducing Kupffer Cell M2 Polarization. Transplantation. 102(6). e265–e274. 45 indexed citations
14.
Li, Tingting, Di Zhu, Tong Mou, et al.. (2017). IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway. Molecular Immunology. 87. 132–140. 78 indexed citations
15.
Mou, Tong, Di Zhu, Xufu Wei, et al.. (2017). Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis. World Journal of Surgical Oncology. 15(1). 63–63. 42 indexed citations
16.
Ma, Yubo, Xufu Wei, & Zhongjun Wu. (2017). HNF‑4α promotes multidrug resistance of gastric cancer cells through the modulation of cell apoptosis. Oncology Letters. 14(6). 6477–6484. 15 indexed citations
17.
Guo, Zhen, Junliang Pu, Daofeng Zheng, et al.. (2016). Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo. International Immunopharmacology. 35. 201–209. 43 indexed citations
18.
Tang, Chengyong, Ai Shen, Xufu Wei, et al.. (2015). Everolimus in de novo liver transplant recipients: a systematic review. Hepatobiliary & pancreatic diseases international. 14(5). 461–469. 16 indexed citations
19.
Fu, Yu, Xufu Wei, Chengyong Tang, et al.. (2013). Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Oncology Letters. 6(6). 1811–1815. 47 indexed citations
20.
Wei, Xufu, Tingxiu Xiang, Guosheng Ren, et al.. (2012). miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cellular Signalling. 25(2). 439–446. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026